P915: TREATMENT PATTERNS AND CLINICAL OUTCOMES OF PATIENTS WITH MULTIPLE MYELOMA PREVIOUSLY TREATED WITH LENALIDOMIDE AND AN ANTI-CD38 MONOCLONAL ANTIBODY: FINDINGS FROM THE CONNECT MM DISEASE REGISTRY

Documenti analoghi

• Impact of lenalidomide-bortezomib-dexamethasone induction on patients with newly diagnosed multiple myeloma and renal impairment: Results from the Connect® MM Registry
  di: Sikander Ailawadhi, et al.
  Pubblicazione: (2024-11-01)
• Connect MM Registry as a national reference for United States multiple myeloma patients
  di: Sikander Ailawadhi, et al.
  Pubblicazione: (2020-01-01)
• Impact of post-ASCT maintenance therapy on outcomes in patients with newly diagnosed multiple myeloma in Connect MM
  di: Sundar Jagannath, et al.
  Pubblicazione: (2018-07-01)
• Lenalidomide-Associated ITP
  di: Christina I. Herold, et al.
  Pubblicazione: (2011-01-01)
• Porche 915 1969-76 autobook/
  di: 206830 Ball, Kenneth
  Pubblicazione: (1978)